DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition

Name: DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
Published: 2023
License: Public Domain

Cancer Research UK · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

adult antineoplastic-agents cancer colorectal-neoplasms melanoma

malignancy, malignant neoplasm, lymphoproliferative disorders, neoplasms by histologic type, neoplasms by site, cancer, colorectal neoplasms, endometrial neoplasms, melanoma, solid tumours, adult, antineoplastic agents

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1030586
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.